| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2024 |
| for |
| Amparo Prosthetics Limited |
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2024 |
| for |
| Amparo Prosthetics Limited |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| Amparo Prosthetics Limited |
| Company Information |
| for the Year Ended 31 December 2024 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| 14 Harvey Road |
| Bedford |
| Bedfordshire |
| MK41 9LF |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Balance Sheet |
| 31 December 2024 |
| 31.12.24 | 31.12.23 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Stocks |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT ASSETS/(LIABILITIES) | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
) |
| CAPITAL AND RESERVES |
| Called up share capital | 8 |
| Share premium | 9 |
| Retained earnings | 9 | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS | ( |
) |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Balance Sheet - continued |
| 31 December 2024 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2024 |
| 1. | STATUTORY INFORMATION |
| Amparo Prosthetics Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Further investment is anticipated in the near future. The directors therefore conclude that there are no material uncertainties which may cast significant doubt regarding the company's ability to continue as a going concern. Accordingly, the company has adopted the going concern basis in preparing the annual report and accounts. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Computer equipment | - |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Computer |
| equipment |
| £ |
| COST |
| At 1 January 2024 |
| and 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.12.24 | 31.12.23 |
| £ | £ |
| Trade debtors |
| Amounts owed by group undertakings |
| Other debtors |
| VAT |
| Prepayments |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.12.24 | 31.12.23 |
| £ | £ |
| Other loans (see note 7) |
| Trade creditors |
| Social security and other taxes |
| Accrued expenses |
| 7. | LOANS |
| An analysis of the maturity of loans is given below: |
| 31.12.24 | 31.12.23 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Convertible loan notes | 233,000 | 233,000 |
| Other loan | 281,384 | 249,996 |
| Whilst the longstop date on the agreements have passed, the convertible loans and loans are expected to either convert into equity or suitable repayment terms to be agreed in the near future. |
| 8. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.12.24 | 31.12.23 |
| value: | £ | £ |
| Ordinary | £0.00 | 1 | 125 | 121 |
| B Ordinary (non-voting) | £0.00 | 1 | 21 | 21 |
| 146 | 142 |
| Amparo Prosthetics Limited (Registered number: 13724212) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 8. | CALLED UP SHARE CAPITAL - continued |
| The following fully paid shares were allotted during the period: |
| 2,834 Ordinary shares of £0.001 each at £11.47 per share |
| 2,285 Ordinary shares of £0.001 each at £21.88 per share |
| 9. | RESERVES |
| Retained | Share |
| earnings | premium | Totals |
| £ | £ | £ |
| At 1 January 2024 | ( |
) | (83,910 | ) |
| Deficit for the year | ( |
) | ( |
) |
| Cash share issue | - | 82,497 | 82,497 |
| Advanced subscription agreement |
- |
91,080 |
91,080 |
| At 31 December 2024 | ( |
) | 62,612 |
| 10. | RELATED PARTY DISCLOSURES |
| During the year to 31 December 2023 W Teerlink, a director of the company, waived an amount previously loaned by himself to Amparo Prosthetics Limited, in the sum of £44,453, in order to facilitate the working capital of the company. |
| 11. | POST BALANCE SHEET EVENTS |
| Post the year end the company acquired a strategic partner in Portugal called Adtechnologies Unipessoal Lda to support logistics and product development. |
| 12. | SHARE-BASED PAYMENT TRANSACTIONS |
| During the year the company implemented an equity-settled share-based payment plan. |
| During the year the company granted 4166 share options to staff under this plan. Options vest on a combination ot time and other milestones. |
| The directors have considered recognising a charge in respect of share based payments. However the directors have agreed that any such charge is not material to the accounts and therefore it has not been included. |